543500 — Evoq Remedies Balance Sheet
0.000.00%
- IN₹80.93m
- IN₹78.78m
- IN₹117.57m
Annual balance sheet for Evoq Remedies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.333 | 30.9 | 1.54 | 1.23 | 2.14 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 77.1 | 291 | 251 | 333 | 365 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 80.5 | 333 | 349 | 368 | 498 |
Net Property, Plant And Equipment | 0 | 0 | 0.093 | 0.14 | 2.23 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 80.5 | 333 | 349 | 369 | 500 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 73 | 102 | 101 | 116 | 54.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 73 | 102 | 101 | 116 | 54.7 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 7.43 | 232 | 248 | 252 | 445 |
Total Liabilities & Shareholders' Equity | 80.5 | 333 | 349 | 369 | 500 |
Total Common Shares Outstanding |